Chinese Journal of Nursing ›› 2022, Vol. 57 ›› Issue (2): 237-244.DOI: 10.3761/j.issn.0254-1769.2022.02.019
• Evidence Synthesis Research • Previous Articles Next Articles
WEI Xiaoxia(
), FU Xin, SHEN Aomei, WANG Yujie, ZHANG Lichuan, LU Qian(
)
Received:2021-07-20
Online:2022-01-20
Published:2022-01-20
Contact:
LU Qian
韦小夏(
), 符鑫, 沈傲梅, 王玉洁, 张力川, 路潜(
)
通讯作者:
路潜
作者简介:韦小夏:女,本科(硕士在读),E-mail: weixiaoxia@bjmu.edu.cn
基金资助:WEI Xiaoxia, FU Xin, SHEN Aomei, WANG Yujie, ZHANG Lichuan, LU Qian. Evidence summary for self-management of lymphedema in breast cancer patients[J]. Chinese Journal of Nursing, 2022, 57(2): 237-244.
韦小夏, 符鑫, 沈傲梅, 王玉洁, 张力川, 路潜. 乳腺癌患者淋巴水肿自我管理的证据总结[J]. 中华护理杂志, 2022, 57(2): 237-244.
Add to citation manager EndNote|Ris|BibTeX
URL: https://zh.zhhlzzs.com/EN/10.3761/j.issn.0254-1769.2022.02.019
| [1] |
Torgbenu E, Luckett T, Buhagiar MA, et al. Prevalence and incidence of cancer related lymphedema in low and middle-income countries:a systematic review and meta-analysis[J]. BMC Cancer, 2020, 20(1):604.
DOI PMID |
| [2] | 刘飞, 路潜, 欧阳倩, 等. 乳腺癌患者术后淋巴水肿与其相关症状的关系研究[J]. 中华护理杂志, 2016, 51(5):518-522. |
| Liu F, Lu Q, Ouyang Q, et al. The relationship between lymphedema status and lymphedema symptoms in breast cancer survivors[J]. Chin J Nurs, 2016, 51(5):518-522. | |
| [3] | 尤渺宁, 康京京, 陆宇晗, 等. 乳腺癌相关淋巴水肿患者综合消肿治疗的居家护理[J]. 中华护理杂志, 2019, 54(8):1238-1240. |
| You MN, Kang JJ, Lu YH, et al. Home nursing care of breast cancer-related lymphedema treated with complete decongestive therapy[J]. Chin J Nurs, 2019, 54(8):1238-1240. | |
| [4] |
Temur K, Kapucu S. The effectiveness of lymphedema self-management in the prevention of breast cancer-related lymphedema and quality of life:a randomized controlled trial[J]. Eur J Oncol Nurs, 2019, 40:22-35.
DOI URL |
| [5] |
Ridner SH, Fu MR, Wanchai A, et al. Self-management of lymphedema:a systematic review of the literature from 2004 to 2011[J]. Nurs Res, 2012, 61(4):291-299.
DOI URL |
| [6] |
Armer JM, Ostby PL, Ginex PK, et al. ONS guidelinesTM for can-cer treatment-related lymphedema[J]. Oncol Nurs Forum, 2020, 47(5):518-538.
DOI PMID |
| [7] |
Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ:advanc-ing guideline development,reporting,and evaluation in health care[J]. Prev Med, 2010, 51(5):421-424.
DOI PMID |
| [8] | 胡雁, 郝玉芳. 循证护理学[M]. 2版. 北京: 人民卫生出版社, 2017: 31. |
| Hu Y, Hao YF. Evidence-based nursing[M]. 2nd ed. Beijing: People’s Publishing House, 2017: 31. | |
| [9] | 王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967. |
| Wang CQ, Hu Y. JBI evidence pre-classification and evidence rank system(2014 edition)[J]. J Nurses Train, 2015, 30(11):964-967. | |
| [10] | The National Comprehensive Cancer Network (NCCN). The NCCN survivorship clinical practices guidelines in oncology(version 1.2021)[EB/OL].(2021-02-24)[2021-05-31].https://www.nccn.org/. |
| [11] | The National Comprehensive Cancer Network (NCCN). Survivorship care for cancer-related late and long-term effects 2020[EB/OL].(2020-07-14)[2021-05-31]. https://www.nccn.org/patientresources/patient-resources. |
| [12] |
Damstra RJ, Halk AB, Dutch Working Group on Lymphedema. The Dutch lymphedema guidelines based on the international classification of functioning,disability,and health and the chronic care model[J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(5):756-765.
DOI PMID |
| [13] | 王惠雪. 乳腺癌术后淋巴水肿预防行为临床实践指南初步构建[D]. 合肥:安徽医科大学, 2017. |
| Wang HX. Primary establishment of clinical practice guideline for preventive behavior of breast cancer-related lymphedema[D]. Hefei:Anhui Medical University, 2017. | |
| [14] | National Institute of Clinical Evidence (NICE). Advanced breast cancer:diagnosis and treatment[EB/OL].(2009-02-23)[2021-05-31].https://www.nice.org.uk/guidance/cg81/resources/advanced-breast-cancer-diagnosis-and-treatment-pdf-975683850181. |
| [15] |
Gebruers N, Verbelen H, de Vrieze T, et al. Current and future perspectives on the evaluation,prevention and conservative management of breast cancer related lymphoedema:a best practice guideline[J]. Eur J Obstet Gynecol Reprod Biol, 2017, 216:245-253.
DOI PMID |
| [16] | JBI. Breast cancer:lymphedema management[EB/OL].(2021-03-09)[2021-05-31]. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=jbi&NEWS=N&A-N=JBI1844. |
| [17] | Australasian Lymphology Association. Lymphoedema management[EB/OL].(2021-01-01)[2021-05-31]. https://www.lympho-edema.org.au/about-lymphoedema/lymphoedema-management/. |
| [18] | American Cancer Society. Lymphedema[EB/OL].(2021-05-25)[2021-05-31]. https://www.cancer.org/treat-ment/treatments-and-side-effects/physical-sideeffects/lymphedema.html. |
| [19] | 中华护理学会. 护理团体标准解读:乳腺癌术后淋巴水肿预防和护理[EB/OL].(2021-03-13)[2021-05-31]. http://www.zhhlxh.org.cn/cnaWebcn/article/3245. |
| Chinese Nursing Association. Prevention and nursing of lym-phedema after breast cancer surgery>[EB/OL].(2021-03-13)[2021-05-31]. http://www.zhhlxh.org.cn/cnaWebcn/article/3245. | |
| [20] | UpToDate. Breast cancer-associated lymphedema[EB/OL].(2021-02-05)[2021-05-31].https://www.uptodate.com/contents/breast-cancer-associated-lymphedema. |
| [21] | 中华整形外科学分会淋巴水肿学组. 外周淋巴水肿诊疗的中国专家共识[J]. 中华整形外科杂志, 2020, 36(4):355-360. |
| Lymphedema Group,Chinese Society of Plastic Surgery. The Chinese consensus of the diagnosis and treatment of peripheral lymphedema[J]. Chin J Plast Surg, 2020, 36(4):355-360. | |
| [22] | Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema:2020 consensus document of the international society of lymphology[J]. Lymphology, 2020, 53(1):3-19. |
| [23] | 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志, 2019, 29(8):609-680. |
| China Anti-Cancer Association, Committee of Breast Cancer Society. Guidelines and norms of breast cancer diagnosis and treatment of China Anti-Cancer Association(2019 edition)[J]. Chin Oncol, 2019, 29(8):609-680. | |
| [24] | 河南省肿瘤医院乳腺癌诊疗共识专家团队. 河南省肿瘤医院乳腺癌相关继发性淋巴水肿诊疗专家共识[J]. 中华肿瘤防治杂志, 2019, 26(24):1855-1858. |
| Expert team of breast cancer diagnosis and treatment consensus in Henan Cancer Hospital. Expert consensus on diagnosis and treatment of secondary lymphoedema in breast cancer in Henan Cancer Hospital[J]. Chin J Cancer Prev Treat, 2019, 26(24):1855-1858. | |
| [25] | BMJ Best Practice. Lymphoedema-treatment algorithm[EB/OL].(2018-04-11)[2021-05-31]. https://bestpractice.bmj.com/topics/en-gb/610/treatment-algorithm. |
| [26] |
McLaughlin SA, de Snyder SM, Klimberg S, et al. Considerations for clinicians in the diagnosis,prevention,and treatment of breast cancer-related lymphedema,recommendations from an expert panel:part 2:preventive and therapeutic options[J]. Ann Surg Oncol, 2017, 24(10):2827-2835.
DOI PMID |
| [27] |
McLaughlin SA, Staley AC, Vicini F, et al. Considerations for clinicians in the diagnosis,prevention,and treatment of breast cancer-related lymphedema:recommendations from a multidisciplinary expert ASBrS panel:part 1:definitions,assessments,education,and future directions[J]. Ann Surg Oncol, 2017, 24(10):2818-2826.
DOI PMID |
| [28] |
Ostby PL, Armer JM, Dale PS, et al. Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema[J]. J Pers Med, 2014, 4(3):424-447.
DOI URL |
| [29] | Cancer Australia. Lymphoedema—what you need to know[EB/OL].(2020-10-20)[2021-05-31]. https://www.canceraustralia.gov.au/affected-cancer/cancer-types/breastcancer/lymphoede-ma.can-cer/lymphoedema. |
| [30] |
Armer JM, Hulett JM, Bernas M, et al. Best practice guidelines in assessment,risk reduction,management,and surveillance for post-breast cancer lymphedema[J]. Curr Breast Cancer Rep, 2013, 5(2):134-144.
PMID |
| [31] | NLN Medical Advisory Committee. Position statement of the National Lymphedema Network[EB/OL].(2012)[2021-05-31]. https://lymphnet.org/position-papers. |
| [32] | Lymphoedema Support Network. Reducing the risk of upper limb lymphoedema Guidance for nurses in acute and community settings[EB/OL].(2011-09-01)[2021-05-31]. https://www.lymphoedema.org/wpcontent/uploads/2020/01/reducing_the_risk_of_upper_limb_lymphoedema.pdf. |
| [33] | 赵权萍, 李凤莲, 路潜. 乳腺癌患者术后淋巴水肿相关知识、危险因素及行为状况的研究[J]. 中华乳腺病杂志(电子版), 2019, 13(5):296-300. |
| Zhao QP, Li FL, Lu Q. Investigation on postoperative lymphedema-related knowledge,risk factors and behaviors of breast cancer patients[J]. Chin J Breast Dis Electron Ed, 2019, 13(5):296-300. | |
| [34] | 刘飞, 司龙妹, 王影新, 等. 乳腺癌相关淋巴水肿患者抗阻力训练的证据总结[J]. 中华护理杂志, 2021, 56(5):755-761. |
| Liu F, Si LM, Wang YX, et al. Evidence summary of resista-nce training for breast cancer-related lymphedema[J]. Chin J Nurs, 2021, 56(5):755-761. | |
| [35] |
Weiler MJ, Cribb MT, Nepiyushchikh Z, et al. A novel mouse tail lymphedema model for observing lymphatic pump failure during lymphedema development[J]. Sci Rep, 2019, 9(1):10405.
DOI URL |
| [36] |
McLaughlin SA, Bagaria S, Gibson T, et al. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery[J]. J Am Coll Surg, 2013, 216(3):380-389.
DOI URL |
| [37] | 刘宁飞. 淋巴水肿:诊断与治疗[M]. 北京: 科学出版社, 2014. |
| Liu NF. Lymphedema-diagosis and treatment[M]. Beijing: Scie-nce Press, 2014. | |
| [38] |
Fu MR, Ridner SH, Armer J. Post-breast cancer lymphedema:part 2[J]. Am J Nurs, 2009, 109(8):34-41.
DOI URL |
| [39] | Lasinski BB, McKillip Thrift K, Squire D, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011[J]. PMR, 2012, 4(8):580-601. |
| [40] |
Wei X, Lu Q, Jin S, et al. Developing and validating a prediction model for lymphedema detection in breast cancer survivors[J]. Eur J Oncol Nurs, 2021, 54:102023.
DOI URL |
| [41] |
Ostby PL, Armer JM, Smith K, et al. Patient perceptions of bar-riers to self-management of breast cancer-related lymphedema[J]. West J Nurs Res, 2018, 40(12):1800-1817.
DOI URL |
| [1] | LIANG Yuanyuan, GAO Xinglian, DAI Zhangzhang, ZHOU Rongchao, HU Juanjuan, WANG Zengyan, SHEN Jianhui. Summary of the best evidence for surgical instrument management strategies in medical institutions [J]. Chinese Journal of Nursing, 2025, 60(8): 1005-1011. |
| [2] | WANG Ting, WANG Jiating, JIN Aiyun, ZHU Xiaming, FANG Yun, WANG Jing, TIAN Fei, PU Yiqin, WAN Ying, HE Jin, YAN Xia. Construction of a nursing follow-up checklist for patients undergoing autologous hematopoietic stem cell transplantation [J]. Chinese Journal of Nursing, 2025, 60(8): 914-920. |
| [3] | SHENG Wanting, WANG Rui, ZHAO Yuxiao, QI Pengfei, GAO Silong, FENG Juan, LÜ Bohan, NIU Qun, WANG Gang. The effectiveness of applying different tip positions of midline catheters:a Meta-analysis [J]. Chinese Journal of Nursing, 2025, 60(8): 990-997. |
| [4] | YAN Xueqin, CAO Songmei, ZHOU Fangfang, ZHU Liqun, CHEN Cheng, ZHU Mengxue, ZHANG Yanhong, LIANG Yiqing, BAI Suping. Summary of best evidence for early rehabilitation management of hand function in patients with hand burns [J]. Chinese Journal of Nursing, 2025, 60(8): 998-1004. |
| [5] | WANG Yi, WANG Xiaohui, WANG Juan, WANG Xiaofeng, GE Jingling. Construction and application of a self-management question prompt list for ovarian cancer postoperative patients [J]. Chinese Journal of Nursing, 2025, 60(7): 806-812. |
| [6] | ZHANG Zhongning, SHEN Aomei, QI Weifang, LI Xin, ZHENG Ruishuang, QIANG Wanmin, WANG Jing. The experience of exercise adherence in breast cancer patients with endocrine-therapy based on the theory of stage change:a qualitative study [J]. Chinese Journal of Nursing, 2025, 60(6): 696-702. |
| [7] | WEI Yongting, TIAN Shumei, YANG Jiao, YU Lianghuan, NI Fu, FAN Yuqing, XIAO Yao, XI Zuyang, SHA Juyan, LIU Cong. Sinicization of Evidence-Informed Decision-Making Competence Measure for nurses and its reliability and validity test [J]. Chinese Journal of Nursing, 2025, 60(6): 736-742. |
| [8] | WANG Wenjing, HAO Wumei, TAI Jingyu, DONG Qian, GUO Aimin. Experience of inhalation therapy in patients with chronic obstructive pulmonary disease:a Meta-synthesis [J]. Chinese Journal of Nursing, 2025, 60(5): 545-551. |
| [9] | Writing Committee:WANG Yingxin, LIU Fei, WU Peipei, ZHANG Lijuan, YANG Funa, YE Li. Expert consensus on home exercise for prevention and rehabilitation of breast cancer related lymphedema/Cancer Rehabilitation Integrated Nursing Committee of Chinese Anti-Cancer Association [J]. Chinese Journal of Nursing, 2025, 60(5): 558-560. |
| [10] | TANG Jiayi, TANG Guiqing, ZHANG Na, LI Xiaobo. Best evidence summary of nutritional management in patients with acute-on-chronic liver failure [J]. Chinese Journal of Nursing, 2025, 60(5): 581-588. |
| [11] | LIU Tingting, NIU Qiaohong, JIAO Xueping, WEI Jiawei, DUAN Shaoming, HU Congli, SU Rui. Meta-synthesis of qualitative studies on the experience of bowel symptoms in patients undergoing sphincter-preserving surgery for rectal cancer [J]. Chinese Journal of Nursing, 2025, 60(5): 603-610. |
| [12] | JIANG Sishan, CHENG Qinqin, LUO Tingwei, ZHANG Na, GUO Junchen, LI Dongya, LI Dandan, ZHU Lihui. A systematic review of quality assessment tools for pediatric palliative care based on COSMlN guidelines [J]. Chinese Journal of Nursing, 2025, 60(5): 611-618. |
| [13] | HU Guifeng, ZHANG Zhijia, PU Congshan, SHAN Chunjian, ZHU Zhu, ZHOU Hui, GAO Yanqiu, KONG Xiaonan. Effect of professional training-based peer support on patients with gestational diabetes mellitus [J]. Chinese Journal of Nursing, 2025, 60(4): 425-431. |
| [14] | Chinese Nursing Association Geriatric Nursing Committee, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, School of Nursing, Peking University(Writing Committee:LIU Wenjing, WANG Zhiwen, YU Yuelin, REN Xin, JU Hui, CHEN Hong WANG Junxin, CHEN Shanshan, ZHOU Jia, YI Mo, WANG Wenxia, ZHANG Lingjuan, CHEN Siye, YANG Yufan, WANG Xiaomeng, SUN Hong). Guideline for assessment and maintenance of intrinsic capacity in older adults [J]. Chinese Journal of Nursing, 2025, 60(3): 261-265. |
| [15] | DUAN Yu, GUO Zhanghui, ZHANG Jie, JIAO Meng, QU Jianni, LIU Guiying, ZHAO Dan, CHEN Yingyu, GUO Hong. Facilitators and barriers to the implementation of exercise for elderly patients with frailty:a qualitative Meta-synthesis [J]. Chinese Journal of Nursing, 2025, 60(3): 288-296. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||